查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532778

肿瘤转录组学市场，按产品类型、应用、技术、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Tumor Transcriptomics Market, By Product type, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年肿瘤转录组学市场规模为57.901亿美元，2024年至2032年复合年增长率为10.10%。

肿瘤转录组学市场-市场动态

增加诊断和药物发现的研究和开发以推动市场需求

诊断和药物发现的研究和开发不断增加、癌症和神经肌肉疾病等慢性疾病盛行率的上升以及转录组学应用的扩大，正在积极推动转录组学市场的成长。转录组学在加速疾病诊断方面发挥着至关重要的作用，特别是在癌症和糖尿病等慢性疾病的全球负担日益增加的情况下。例如，根据 GLOBOCAN 2020 报告，全球约有 1,920 万新发癌症病例和 990 万癌症死亡病例。患者人数的增加预计将对市场成长产生正面影响。预计市场成长将受到主要市场参与者的产品发布、扩张、合作和收购的显着推动。例如，2020 年 2 月，Caris Life Sciences 推出了其最新的基因组分析产品 MI Transcriptome，该产品利用全转录组定序 (WTS)。该技术能够对患者肿瘤进行详细的 RNA 分析，并补充了 Caris 评估 DNA、RNA 和蛋白质以准确定制治疗方案的综合方法。此类产品的推出将对市场扩张产生正面影响。同样，2020 年 2 月，Dovetail Genomics 透过推出 Dovetail HiChIP 和 Micro-C 试剂盒扩大了其全球影响力，旨在扩大其全球客户群并进一步刺激市场成长。

肿瘤转录组学市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 10.10% 左右的复合年增长率成长

根据产品类型细分，预计仪器将在 2023 年显示最大的市场份额

从技术细分来看，定序技术是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

肿瘤转录组学市场-細項分析：

全球肿瘤转录组学市场根据产品类型、应用、技术和地区进行细分。

市场依产品类型分为三类：消耗品、仪器和其他产品。就产品类型而言，仪器因其在转录组分析中的关键作用而占据主导地位。微阵列扫描仪、即时定量 PCR 机和下一代定序平台等仪器对于产生资料和执行高通量转录组分析至关重要。这些仪器对于寻求了解疾病机制、识别生物标记和製定个人化治疗策略的研究人员和临床医生至关重要，从而巩固其在市场上的主导地位。

市场依技术分为三类：微阵列、即时定量聚合酶连锁反应（Q-PCR）及定序技术。在转录组学市场中，定序技术因其高解析度分析转录组的先进能力而在技术领域占据主导地位。 RNA 定序 (RNA-Seq) 使研究人员能够检测稀有转录物、研究选择性剪接事件并准确量化基因表现水平，从而彻底改变了转录组学研究。该技术能够提供对基因表现谱和分子途径的全面见解，使其在研究和临床应用中不可或缺，从而推动其在市场上的主导地位。

肿瘤转录组学市场 - 地理洞察

从地理角度来看，该市场涵盖广阔的地理区域，横跨北美、拉丁美洲、欧洲、亚太地区、中东和非洲。这些地区内的各国制定了进一步的市场分类。在政府有利倡议、医疗保健支出不断增加、行业领导者的强大影响力、先进的医疗保健基础设施、医疗保健利益相关者对可用技术的认识提高以及市场参与者高度集中的推动下，北美预计将引领市场，尤其是在美国。

肿瘤转录组学市场-竞争格局：

肿瘤转录组学市场是指专注于肿瘤基因表现模式研究和分析的领域。它涉及旨在了解癌细胞转录组的技术和方法，这可以提供对肿瘤生物学、疾病进展和潜在治疗标靶的见解。该市场公司采取的关键策略包括开发先进的测序技术、与研究机构和製药公司建立资料共享和临床试验的合作、以及增强生物资讯学能力以有效解释复杂的基因组资料。该市场的推动因素包括肿瘤学研究投资的增加、个人化医疗方法以及基于基因组分析的标靶癌症疗法不断增长的需求。转录组学领域的各种市场参与者继续专注于创新疾病诊断的新仪器和技术。

最新进展：

2021 年 8 月，HTG Molecular Diagnostics, Inc. 在美国和欧洲推出了 HTG 转录组面板。该面板采用 HTG EdgeSeq 技术，可测量近 20,000 个 mRNA 标靶，并已证明诊断多种癌症的可重复性。这些进步和发布预计将促进该领域的成长。

目录

第一章：肿瘤转录组学市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的肿瘤转录组学市场片段
    • 按应用分類的肿瘤转录组学市场片段
    • 肿瘤转录组学市场技术摘要
    • 按国家/地区分類的肿瘤转录组学市场片段
    • 按地区分類的肿瘤转录组学市场片段
  • 竞争洞察

第 3 章：肿瘤转录组学主要市场趋势

  • 肿瘤转录组学市场驱动因素
    • 市场驱动因素的影响分析
  • 肿瘤转录组学市场限制
    • 市场限制影响分析
  • 肿瘤转录组学市场机会
  • 肿瘤转录组学市场未来趋势

第 4 章：肿瘤转录组学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：肿瘤转录组学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：肿瘤转录组学市场格局

  • 2023 年肿瘤转录组学市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：肿瘤转录组学市场 - 依产品类型

  • 概述
    • 细分市场占有率分析（依产品类型）
    • 耗材
    • 仪器仪表
    • 其他产品

第 8 章：肿瘤转录组学市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 诊断和疾病分析
    • 药物发现
    • 其他应用

第 9 章：肿瘤转录组学市场 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 微阵列
    • 即时定量聚合酶炼式反应 (Q-PCR)
    • 定序技术

第 10 章：肿瘤转录组学市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美肿瘤转录组学主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按技术）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲肿瘤转录组学主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按技术）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区肿瘤转录组学主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（按技术）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲肿瘤转录组学主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按技术）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲肿瘤转录组学主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按技术）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-肿瘤转录组学产业

  • 竞争仪表板
  • 公司简介
    • 10x Genomics
    • Agilent Technologies Inc.
    • BGI Genomics
    • Bio-Rad Laboratories Inc.
    • Dovetail Genomics
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • GE Healthcare
    • Illumina Inc.
    • Merck KGaA
    • Natera Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3396

REPORT HIGHLIGHT

Tumor Transcriptomics Market size was valued at USD 5,790.10 Million in 2023, expanding at a CAGR of 10.10% from 2024 to 2032.

Tumor transcriptomics involves analyzing the gene expression profiles of tumors by examining RNA molecules (transcripts). This method identifies genes that are either over-expressed or under-expressed compared to healthy tissue, revealing the molecular characteristics of tumors. This approach offers insights into how tumors develop, progress, and potential targets for treatment. Tumor transcriptomics is crucial for personalized medicine as it allows for the identification of key mutations driving cancer and facilitates the customization of treatment plans based on the specific transcriptional profile of each tumor.

Tumor Transcriptomics Market- Market Dynamics

Increasing research and development in diagnostics and drug discovery to propel market demand

The growth of the transcriptomics market is being actively driven by increasing research and development in diagnostics and drug discovery, the rising prevalence of chronic diseases like cancer and neuromuscular disorders, and expanding applications of transcriptomics. Transcriptomics plays a crucial role in accelerating disease diagnostics, especially with the growing global burden of chronic diseases such as cancer and diabetes. For example, according to the GLOBOCAN 2020 report, there were approximately 19.2 million new cancer cases and 9.9 million cancer deaths worldwide. This increasing patient population is expected to positively impact market growth. The market growth is anticipated to be significantly driven by product launches, expansions, collaborations, and acquisitions from key market players. For example, in February 2020, Caris Life Sciences introduced its latest genomic profiling offering, MI Transcriptome, which utilizes Whole Transcriptome Sequencing (WTS). This technology enables detailed RNA profiling of patients' tumors, complementing Caris' comprehensive approach that assesses DNA, RNA, and proteins to tailor therapies accurately. Such launches are poised to positively impact market expansion. Similarly, in February 2020, Dovetail Genomics expanded its global reach with the availability of Dovetail HiChIP and Micro-C Kits, aiming to broaden its customer base worldwide and further stimulate market growth.

Tumor Transcriptomics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.10% over the forecast period (2024-2032)

Based on Product type segmentation, instruments was predicted to show maximum market share in the year 2023

Based on technology segmentation, sequencing technologies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Tumor Transcriptomics Market- Segmentation Analysis:

The Global Tumor Transcriptomics Market is segmented on the basis of Product type, Application, Technology, and Region.

The market is divided into three categories based on Product type: Consumables, Instruments, and Other Products. In terms of product types, instruments hold a dominant position due to their critical role in conducting transcriptomic analyses. Instruments such as microarray scanners, real-time quantitative PCR machines, and next-generation sequencing platforms are essential for generating data and performing high-throughput transcriptome analysis. These instruments are pivotal for researchers and clinicians seeking to understand disease mechanisms, identify biomarkers, and develop personalized treatment strategies, thereby solidifying their dominance in the market.

The market is divided into three categories based on technology: Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR) and Sequencing Technologies. In the transcriptomics market, sequencing technologies dominate the technology segment due to their advanced capabilities in analyzing the transcriptome with high resolution. RNA sequencing (RNA-Seq) has revolutionized transcriptomic studies by allowing researchers to detect rare transcripts, study alternative splicing events, and quantify gene expression levels accurately. This technology's ability to provide comprehensive insights into gene expression profiles and molecular pathways has made it indispensable in both research and clinical applications, driving its dominance in the market.

Tumor Transcriptomics Market- Geographical Insights

From a territorial perspective, this market covers a vast geographic area, stretching across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Individual countries within these regions create further market classifications. North America is projected to lead the market, fueled by favorable government initiatives, rising healthcare spending, a robust presence of industry leaders, advanced healthcare infrastructure, heightened awareness among healthcare stakeholders about available technologies, and a high concentration of market players, particularly in the United States.

Tumor Transcriptomics Market- Competitive Landscape:

The Tumor Transcriptomics market refers to the sector focused on the study and analysis of gene expression patterns in tumors. It involves technologies and methodologies aimed at understanding the transcriptome of cancer cells, which can provide insights into tumor biology, disease progression, and potential therapeutic targets. Key strategies adopted by companies in this market include developing advanced sequencing technologies, establishing collaborations with research institutions and pharmaceutical companies for data sharing and clinical trials, and enhancing bioinformatics capabilities to interpret complex genomic data effectively. The market is driven by increasing research investments in oncology, personalized medicine approaches, and the growing demand for targeted cancer therapies based on genomic profiling. Various market participants in the transcriptomics sector continue to focus on innovating new instruments and techniques for disease diagnostics.

Recent Developments:

In August 2021, HTG Molecular Diagnostics, Inc. launched its HTG Transcriptome Panel in the U.S. and Europe. This panel, utilizing HTG EdgeSeq technology, can measure nearly 20,000 mRNA targets and has demonstrated repeatability for diagnosing multiple cancers. These advancements and launches are expected to bolster growth within this segment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUMOR TRANSCRIPTOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

10x Genomics

Agilent Technologies Inc.

BGI Genomics

Bio-Rad Laboratories Inc.

Dovetail Genomics

F. Hoffmann-La Roche AG

Fluidigm Corporation

GE Healthcare

Illumina Inc.

Merck KGaA

Natera Inc.

Others

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Consumables
  • Instruments
  • Other Products

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diagnostics and Disease Profiling
  • Drug Discovery
  • Other Applications

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Microarray
  • Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
  • Sequencing Technologies

GLOBAL TUMOR TRANSCRIPTOMICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tumor Transcriptomics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tumor Transcriptomics Market Snippet by Product type
    • 2.1.2. Tumor Transcriptomics Market Snippet by Application
    • 2.1.3. Tumor Transcriptomics Market Snippet by Technology
    • 2.1.4. Tumor Transcriptomics Market Snippet by Country
    • 2.1.5. Tumor Transcriptomics Market Snippet by Region
  • 2.2. Competitive Insights

3. Tumor Transcriptomics Key Market Trends

  • 3.1. Tumor Transcriptomics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tumor Transcriptomics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tumor Transcriptomics Market Opportunities
  • 3.4. Tumor Transcriptomics Market Future Trends

4. Tumor Transcriptomics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tumor Transcriptomics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tumor Transcriptomics Market Landscape

  • 6.1. Tumor Transcriptomics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tumor Transcriptomics Market - By Product type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product type, 2023 & 2032 (%)
    • 7.1.2. Consumables
    • 7.1.3. Instruments
    • 7.1.4. Other Products

8. Tumor Transcriptomics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostics and Disease Profiling
    • 8.1.3. Drug Discovery
    • 8.1.4. Other Applications

9. Tumor Transcriptomics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 9.1.2. Microarray
    • 9.1.3. Real-time Quantitative Polymerase Chain Reaction (Q-PCR)
    • 9.1.4. Sequencing Technologies

10. Tumor Transcriptomics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Tumor Transcriptomics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Tumor Transcriptomics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Tumor Transcriptomics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Tumor Transcriptomics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Tumor Transcriptomics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Tumor Transcriptomics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 10x Genomics
    • 11.2.2. Agilent Technologies Inc.
    • 11.2.3. BGI Genomics
    • 11.2.4. Bio-Rad Laboratories Inc.
    • 11.2.5. Dovetail Genomics
    • 11.2.6. F. Hoffmann-La Roche AG
    • 11.2.7. Fluidigm Corporation
    • 11.2.8. GE Healthcare
    • 11.2.9. Illumina Inc.
    • 11.2.10. Merck KGaA
    • 11.2.11. Natera Inc.
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Tumor Transcriptomics Market: Product type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product type
  • TABLE Global Tumor Transcriptomics Market, by Product type 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Tumor Transcriptomics Market, by Application 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Tumor Transcriptomics Market, by Technology 2019-2032 (USD Million)
  • TABLE Tumor Transcriptomics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Tumor Transcriptomics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Product type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Tumor Transcriptomics Market, by Technology, 2019-2032 (USD Million)

List of Figures

  • FIGURE Tumor Transcriptomics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product type segment market share analysis, 2023 & 2032
  • FIGURE Product type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Technology segment market share analysis, 2023 & 2032
  • FIGURE Technology segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Europe Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Asia Pacific Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Latin America Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE Middle East and Africa Tumor Transcriptomics Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Germany Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE India Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Brazil Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Tumor Transcriptomics Market share analysis by country, 2023
  • FIGURE Saudi Arabia Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Tumor Transcriptomics Market size, forecast and trend analysis, 2019 to 2032 (USD Million)